BMI1 and neoplasm: In our previous study, we showed that BMI1 mRNA expression in primary NSCLC tumors is positively associated with BMI1 mRNA expression in peripheral whole blood of operable NSCLC patients, suggesting the potential of measuring BMI1 mRNA in whole blood as a surrogate marker of tumor progression [26].